Strides Pharma Science Limited has informed the Exchange about Schedule of Analyst/ Institutional Investor s Meet
STAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Strides Pharma Science has informed the exchanges that it will participate in the 'Ashwamedh, Elara India Dialogue 2025', an investor conference organised by Elara Capital. The meeting is scheduled for September 2, 2025, from 11:00 hrs onwards, in Mumbai, and will be held in an in-person one-on-one format. The discussion during these meetings will be based on the company's Q1 FY26 earnings deck, which was already uploaded to the stock exchanges and the company website on July 29, 2025. This filing is a routine disclosure under SEBI's Listing Regulations and does not contain any new financial information.
This is a routine investor outreach event and no new financial data is being shared. Since the discussions will be based on the already-disclosed Q1 FY26 earnings, any immediate stock price impact is expected to be minimal, though one-on-one meetings can sometimes lead to additional clarifications on strategy or outlook.